Closure of trading window for the quarter ended June 30, 2026.

Date: September 01, 2026 Sr. General Manager Sr. General Manager Listing Department Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Dalal Street, Exchange Plaza, C-1, Block G Mumbai - 400001. Bandra -Kurla Complex, Bandra (East), Mumbai- 400051. Scrip Code: 544889 Scrip Symbol : SYMBIOTEC ISIN: INE899I01028 ISIN: INE899I01028 Subject: Intimation of Closure of Trading Window pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 Dear Sir/Madam, Pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time, we wish to inform you that in terms of Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the trading window for dealing in securities of the Company will remain closed for all Designated Person and their immediate relatives from Tuesday, September 01, 2026 till 48 hours after the declaration of unaudited Financial Results of the Company for the quarter ended June 30, 2026. The same is being informed to the designated person and connected person in accordance with the Company’s Code of Conduct for Prohibition of Insider trading. Further, the date of meeting of the Board of Directors of the Company to consider and approve the unaudited Financial Results of the Company for the said period shall be informed in due course. Kindly take the same on record. Thanking You, For SYMBIOTEC PHARMALAB LIMITED Salil Jain Company Secretary and Compliance Officer Membership No. A41610 Registered Office & Works: Symbiotec Pharmalab Limited (Formerly known as Symbiotec Pharmalab Pvt. Ltd.) 385/2, Pigdamber, Rau, Mhow, Indore - 453331, Madhya Pradesh, India Tel. No.: +91-731-6676405-406 Fax: +91-731-4201222, Email ID : symbiotec@symbiotec.com, Website : www.symbiotec.com CIN: U24232MP2002PLC015293